Published in J Infect Dis on January 01, 1973
Susceptibility of lipopolysaccharide mutants to the bactericidal action of human neutrophil lysosomal fractions. Infect Immun (1977) 3.21
PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev (1998) 2.69
The role of lactoferrin in the bactericidal function of polymorphonuclear leucocytes. Immunology (1979) 2.20
Bactericidal activity of specific and azurophil granules from human neutrophils: studies with outer-membrane mutants of Salmonella typhimurium LT-2. Infect Immun (1978) 2.04
Distinct C/EBP functions are required for eosinophil lineage commitment and maturation. Genes Dev (1998) 1.66
NF-M (chicken C/EBP beta) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line. EMBO J (1995) 1.45
The polymorphonuclear leukocyte. Agents Actions (1978) 1.43
Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors. J Cell Biol (1997) 1.39
New avian model of experimental glomerulonephritis consistent with mediation by cellular immunity. Nonhumorally mediated glomerulonephritis in chickens. J Clin Invest (1984) 1.12
Chicken neutrophils: oxidative metabolism in phagocytic cells devoid of myeloperoxidase. Proc Natl Acad Sci U S A (1975) 1.08
Bactericidal activity of granule contents from rat polymorphonuclear leukocytes. Infect Immun (1983) 0.97
Isozymes of lysozyme in leukocytes and egg white: evidence for the species-specific control of egg-white lysozyme synthesis. Proc Natl Acad Sci U S A (1974) 0.86
Electron microscopic and enzyme cytochemical studies on granules of mature chicken granular leucocytes. J Anat (1977) 0.86
Characterization of monkey peripheral neutrophil granules during infection. Infect Immun (1975) 0.82
Characterization of canine neutrophil granules. Infect Immun (1982) 0.81
Cationic proteins of polymorphonuclear leukocyte lysosomes. II. Composition, properties, and mechanism of antibacterial action. J Bacteriol (1966) 4.81
Arginine-rich proteins of polymorphonuclear leukocyte lysosomes. Antimicrobial specificity and biochemical heterogeneity. J Exp Med (1968) 4.49
Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest (1974) 4.09
Cationic proteins of polymorphonuclear leukocyte lysosomes. I. Resolution of antibacterial and enzymatic activities. J Bacteriol (1966) 3.61
Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate. Infect Immun (1984) 3.32
Susceptibility of lipopolysaccharide mutants to the bactericidal action of human neutrophil lysosomal fractions. Infect Immun (1977) 3.21
Association of lactoferrin with lysozyme in granules of human polymorphonuclear leukocytes. Infect Immun (1972) 2.58
Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence. J Bacteriol (1993) 2.46
Lipid A and resistance of Salmonella typhimurium to antimicrobial granule proteins of human neutrophil granulocytes. Infect Immun (1984) 2.41
Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. I. Loss of label, death, and ultrastructural damage. J Bacteriol (1966) 2.30
Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes: antagonism of granule cationic proteins by lipopolysaccharide. Infect Immun (1979) 2.17
Bactericidal activity of specific and azurophil granules from human neutrophils: studies with outer-membrane mutants of Salmonella typhimurium LT-2. Infect Immun (1978) 2.04
Distribution of lysosomal enzymes, cationic proteins, and bactericidal substances in subcellular fractions of human polymorphonuclear leukocytes. Infect Immun (1971) 2.01
Cationic protein-bearing granules of polymorphonuclear leukocytes: separation from enzyme-rich granules. Science (1969) 2.00
Nonoxidative antimicrobial reactions of leukocytes. Contemp Top Immunobiol (1984) 1.97
Assessment of phagocytic and antimicrobial activity of human granulocytes. Infect Immun (1974) 1.96
Quantitative detection of Borrelia burgdorferi by real-time PCR. J Clin Microbiol (1999) 1.93
The venous graft as an effector of early angiogenesis in a fibrin matrix. Microvasc Res (2007) 1.93
Bactericidal activity of fractionated granule contents from human polymorphonuclear leukocytes. Infect Immun (1979) 1.89
Women encounter ADRs more often than do men. Eur J Clin Pharmacol (2008) 1.83
Characterization of cationic protein-bearing granules of polymorphonuclear leukocytes. Lab Invest (1971) 1.79
Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol (1970) 1.79
Immunocytochemical localization of myeloperoxidase, lactoferrin, lysozyme and neutral proteases in human monocytes and neutrophilic granulocytes. J Reticuloendothel Soc (1978) 1.74
Intracellular and extracellular degranulation of human polymorphonuclear azurophil and specific granules induced by immune complexes. Infect Immun (1974) 1.73
cDNA cloning of human myeloperoxidase: decrease in myeloperoxidase mRNA upon induction of HL-60 cells. Proc Natl Acad Sci U S A (1987) 1.67
Molecular and structural damage to Escherichia coli produced by antibody, complement, and lysozyme systems. J Bacteriol (1968) 1.64
Gastrointestinal ulcerations induced by anti-inflammatory drugs in rats. Physicochemical and biochemical factors involved. Arch Toxicol (1990) 1.59
The role of lysosomes in hypersensitivity reactions: tissue damage by polymorphonuclear neutrophil lysosomes. J Immunol (1965) 1.59
Antimicrobial specificity of leukocyte lysosomal cationic proteins. Science (1966) 1.58
Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes. Lab Invest (1977) 1.57
Early degranulation of human neutrophils: immunocytochemical studies of surface and intracellular phagocytic events. Cell (1979) 1.56
Late intraphagosomal hydrogen ion concentration favors the in vitro antimicrobial capacity of a 37-kilodalton cationic granule protein of human neutrophil granulocytes. Infect Immun (1986) 1.53
Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. 3. Isolation of a gammag normal antibody and characterization of other serum factors causing P32 loss. J Bacteriol (1966) 1.52
Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf (2000) 1.51
Anaerobiosis increases resistance of Neisseria gonorrhoeae to O2-independent antimicrobial proteins from human polymorphonuclear granulocytes. Infect Immun (1985) 1.47
CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J Clin Invest (1990) 1.46
Synthetic bactericidal peptide based on CAP37: a 37-kDa human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc Natl Acad Sci U S A (1993) 1.45
Normal serum cytotoxicity for P32-labeled smooth Enterobacteriaceae. II. Fate of macromolecular and lipid phosphorus of damaged cells. J Bacteriol (1966) 1.44
Pharmacological control of prostaglandin and thromboxane release from macrophages. Nature (1978) 1.44
Readmissions and adverse drug reactions in internal medicine: the economic impact. J Intern Med (2004) 1.42
Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol (2000) 1.42
Fate of human lactoferrin and myeloperoxidase in phagocytizing human neutrophils: effects of immunoglobulin G subclasses and immune complexes coated on latex beads. Infect Immun (1975) 1.42
Lipopolysaccharide structure determines ionic and hydrophobic binding of a cationic antimicrobial neutrophil granule protein. Infect Immun (1988) 1.42
Outer membrane mutants of Salmonella typhimurium LT2 have lipopolysaccharide-dependent resistance to the bactericidal activity of anaerobic human neutrophils. Infect Immun (1982) 1.39
Isolation of polymorphonuclear leukocyte granules from rabbit bone marrow. Lab Invest (1971) 1.39
Subcellular distribution of superoxide dismutases in human neutrophils. Influence of myeloperoxidase on the measurement of superoxide dismutase activity. Biochem J (1977) 1.38
Isolation and characterization of a gene, pmrD, from Salmonella typhimurium that confers resistance to polymyxin when expressed in multiple copies. J Bacteriol (1994) 1.37
O antigen and lipid A phosphoryl groups in resistance of Salmonella typhimurium LT-2 to nonoxidative killing in human polymorphonuclear neutrophils. Infect Immun (1989) 1.37
Inhibition of anti-inflammatory drugs of prostaglandin production in cultured macrophages. Naunyn Schmiedebergs Arch Pharmacol (1981) 1.36
Leukocytes and prostaglandins in acute inflammation. Experientia (1974) 1.35
Pyrogenicity of granulocyte lysosomes. Am J Physiol (1966) 1.33
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Elevated serum cyclophilin levels in patients with severe sepsis. J Clin Immunol (1997) 1.28
An enzyme-linked immunoassay (ELISA) for measurement of lactoferrin. J Immunol Methods (1983) 1.28
Immunocytochemical identification of azurophilic and specific granule markers in the giant granules of Chediak-Higashi neutrophils. N Engl J Med (1978) 1.26
Amino acid sequence of CAP37, a human neutrophil granule-derived antibacterial and monocyte-specific chemotactic glycoprotein structurally similar to neutrophil elastase. FEBS Lett (1990) 1.25
Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol (1999) 1.24
Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay. J Clin Invest (1977) 1.22
Myeloperoxidase-Cl--H2O2 bactericidal system: effect of bacterial membrane structure and growth conditions. Infect Immun (1978) 1.22
Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants. J Immunol (1970) 1.22
Lysosomal enzymes in inflammatory synovial effusions. J Immunol (1979) 1.18
Possible role of oxygen free radicals in ethanol-induced gastric mucosal damage in rats. Dig Dis Sci (1988) 1.17
Subcellular distribution of glycosidases in human polymorphonuclear leucocytes. Biochem J (1978) 1.16
Neisseria gonorrhoeae survive intraleukocytic oxygen-independent antimicrobial capacities of anaerobic and aerobic granulocytes in the presence of pyocin lethal for extracellular gonococci. Infect Immun (1986) 1.15
Biodistribution of mild analgesics. Br J Clin Pharmacol (1980) 1.12
Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin Pharmacol Ther (2002) 1.12
Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia (1975) 1.11
Rat arthritis due to whole group B streptococci. Clinical and histopathologic features compared with groups A and D. Am J Pathol (1983) 1.11
Microbicidal activity of peroxidaseless chicken heterophile leukocytes. Infect Immun (1972) 1.10
Immunocytochemical distinction between primary and secondary granule formation in developing human neutrophils: correlations with Romanowsky stains. Blood (1979) 1.10
Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals. Br J Clin Pharmacol (1999) 1.10
Correlation between antimicrobial activity and peroxidase content of leukocytes. Nature (1973) 1.10
Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth (1993) 1.10
Prostaglandin release from macrophages: an assay system for anti-inflammatory drugs in vitro. Agents Actions (1977) 1.08
Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2000) 1.08
Chicken neutrophils: oxidative metabolism in phagocytic cells devoid of myeloperoxidase. Proc Natl Acad Sci U S A (1975) 1.08
Neutrophil killing of bacteria by oxygen-independent mechanisms: a historical summary. Rev Infect Dis (1985) 1.08
Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations. Agents Actions Suppl (1986) 1.07
Antibacterial action of PMN lysosomal cationic proteins resolved by density gradient electrophoresis. Proc Soc Exp Biol Med (1966) 1.07
Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J Immunol (1991) 1.06
Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters. Agents Actions (1990) 1.06
Antimicrobial binding of a radiolabeled cationic neutrophil granule protein. Infect Immun (1987) 1.06
Ultrastructural localization of cationic proteins in cytoplasmic granules of chicken and rabbit polymorphonuclear leukocytes. J Cell Sci (1975) 1.06
Gonococci with mutations to low-level penicillin resistance exhibit increased sensitivity to the oxygen-independent bactericidal activity of human polymorphonuclear leukocyte granule extracts. Infect Immun (1982) 1.06
Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol (1994) 1.05
The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population. Blood (1990) 1.04
Dissociation between the antinociceptive and anti-inflammatory effects of the nonsteroidal anti-inflammatory drugs. A survey of their analgesic efficacy. Drugs (1991) 1.04
Differential effects of ketamine enantiomers on NMDA receptor currents in cultured neurons. Eur J Pharmacol (1992) 1.02
Characteristics of complement-dependent release of phospholipid from Escherichia coli. Infect Immun (1971) 1.01
Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration. Clin Pharmacol Ther (1999) 1.01
Serum antibodies against chondrocyte cell surface proteins in osteoarthritis and rheumatoid arthritis. J Rheumatol (1988) 1.01
Nonoxidative antimicrobial effects of human polymorphonuclear leukocyte granule proteins on Chlamydia spp. in vitro. Infect Immun (1987) 1.01
Neutral proteases confined to one class of lysosomes of human polymorphonuclear leukocytes. Proc Soc Exp Biol Med (1972) 1.00
Computerized survelliance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol (1998) 1.00
Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun (2000) 0.99
Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci (2000) 0.99
Effects of pure enantiomers of flurbiprofen in comparison to racemic flurbiprofen on eicosanoid release from various rat organs ex vivo. Prostaglandins (1991) 0.99
Isolation and characterization of an acidic chemotactic factor from complement-activated human serum. Clin Immunol Immunopathol (1980) 0.98